Manolache, D
667  Ergebnisse:
Personensuche X
?
 
?
2

Quality of life measurement in rosacea. Position statement ..:

Chernyshov, P. V. ; Finlay, A. Y. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  5 - p. 954-964 , 2023
 
?
3

Quality of life measurement in teledermatology. Position st..:

Chernyshov, P. V. ; Finlay, A. Y. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  2 - p. 254-264 , 2023
 
?
4

Bullying in persons with skin diseases:

Chernyshov, P. V. ; Tomas‐Aragones, L. ; Manolache, L....
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  4 - p. 752-760 , 2023
 
?
5

Analysis and development on general structure and character..:

Gheorghe, M ; Stochioiu, F P G ; Manolache, D..
IOP Conference Series: Materials Science and Engineering.  1268 (2022)  1 - p. 012010 , 2022
 
?
6

Quality of life assessment in core outcome sets: A position..:

Chernyshov, P.V. ; Evers, A.W.M. ; Bewley, A....
Journal of the European Academy of Dermatology and Venereology.  36 (2021)  1 - p. 20-23 , 2021
 
?
7

Quality of life measurement in alopecia areata. Position st..:

Chernyshov, P.V. ; Tomas‐Aragones, L. ; Finlay, A.Y....
Journal of the European Academy of Dermatology and Venereology.  35 (2021)  8 - p. 1614-1621 , 2021
 
?
8

Analysis and development of a key performance indicators mo..:

Tieber, A ; Manolache, D ; Gheorghe, M
IOP Conference Series: Materials Science and Engineering.  1018 (2021)  1 - p. 012026 , 2021
 
?
9

Position statement of the European Academy of Dermatology a..:

Chernyshov, P.V. ; Tomas‐Aragones, L. ; Augustin, M....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  8 - p. 1666-1671 , 2020
 
?
10

Quality of life measurement in occupational skin diseases. ..:

Chernyshov, P.V. ; John, S.M. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  9 - p. 1924-1931 , 2020
 
?
11

Methods to improve quality of life, beyond medicines. Posit..:

Finlay, A.Y. ; Chernyshov, P.V. ; Tomas Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  35 (2020)  2 - p. 318-328 , 2020
 
?
12

Quality of life measurement in skin cancer patients: litera..:

Chernyshov, P.V. ; Lallas, A. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  33 (2019)  5 - p. 816-827 , 2019
 
?
13

Why use an allergy‐based quality of life measure in childho..:

Manolache, L. ; Finlay, A.Y.
British Journal of Dermatology.  181 (2019)  2 - p. 240-241 , 2019
 
?
14

Validation of the dermatology‐specific proxy instrument the..:

Chernyshov, P.V. ; Sampogna, F. ; Pustišek, N....
Journal of the European Academy of Dermatology and Venereology.  33 (2019)  7 - p. 1405-1411 , 2019
 
?
15

Quality of life measurement in hidradenitis suppurativa: po..:

Chernyshov, P.V. ; Zouboulis, C.C. ; Tomas‐Aragones, L....
Journal of the European Academy of Dermatology and Venereology.  33 (2019)  9 - p. 1633-1643 , 2019
 
1-15